secwatch.observer — SEC 8-K summary
======================================

Issuer:     Glucotrack, Inc. (GCTK)
CIK:        0001506983
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0001641172-25-013543
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glucotrack to present first-in-human CBGM data at ADA 85th Scientific Sessions
------------------------------------------------------------------------------

- Will present safety & performance data from first-in-human trial of implantable continuous blood glucose monitor (CBGM).
- Live presentation by CSO Mark Tapsak on June 21 in Innovation Hub; poster session June 22.
- CBGM measures glucose directly from blood, lasts up to 3 years, no on-body wearable.
- Company preparing for next clinical phase (long-term feasibility study).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506983/000164117225013543/0001641172-25-013543-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506983/000164117225013543/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-013543

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer